MiNK Therapeutics Inc.

NASDAQ: INKT · Real-Time Price · USD
16.63
1.31 (8.55%)
At close: Aug 15, 2025, 3:04 PM

MiNK Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.58M 3.37M 19.64M 38.89M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -0.00 0.00
Receivables
n/a n/a n/a 23K
Inventory
n/a n/a n/a 1.76K
Other Current Assets
164.24K 177.96K 470.3K 721.32K
Total Current Assets
4.99M 3.6M 20.4M 39.63M
Property-Plant & Equipment
732.93K 953.98K 1.07M 606.6K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
732.93K 953.98K 1.07M 606.6K
Total Assets
5.72M 4.55M 21.47M 40.24M
Account Payables
2.73M 3.91M 5.82M 3M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
3.51M 5.66M 5.21M 12.89M
Total Current Liabilities
6.96M 11.4M 12.68M 16.47M
Long-Term Debt
4.92M n/a n/a n/a
Other Long-Term Liabilities
13.42M 11.21M 9.19M n/a
Total Long-Term Liabilities
18.35M 11.21M 9.19M n/a
Total Liabilities
25.31M 22.61M 21.87M 16.47M
Total Debt
4.92M n/a n/a n/a
Common Stock
40.00 346.00 339.00 335.00
Retained Earnings
-144.18B -133.4M -110.94M -82.95M
Comprehensive Income
-631.58M -430.95K -292.47K -625.27K
Shareholders Equity
-19.59M -18.06M -401.3K 23.78M
Total Investments
4.57B n/a n/a n/a